COMPASS PATHW SP.ADR (5Y6) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.477x

Based on the latest financial reports, COMPASS PATHW SP.ADR (5Y6) has a cash flow conversion efficiency ratio of -0.477x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-40.31 Million ≈ $-47.12 Million USD) by net assets (€84.53 Million ≈ $98.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see COMPASS PATHW SP.ADR (5Y6) total market value for the company's overall valuation and market capitalisation.

COMPASS PATHW SP.ADR - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how COMPASS PATHW SP.ADR's cash flow conversion efficiency has evolved over time, based on yearly financial data.

COMPASS PATHW SP.ADR Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of COMPASS PATHW SP.ADR ranked by their cash flow conversion efficiency. Explore 5Y6 cash flow quality score to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
IRESS LTD
F:BRF
N/A
Everlight Chemical Industrial Corp
TW:1711
0.045x
IntelliEPI Cayman
TWO:4971
0.015x
Cromwell Property Group
AU:CMW
0.023x
Shenzhen TXD Technology Co Ltd
SHE:002845
-0.017x
Hebei Huijin Electromechanical Co Ltd
SHE:300368
-0.047x
Ciputra Development Tbk
JK:CTRA
0.004x
Liberty Broadband Srs A
NASDAQ:LBRDA
-0.012x

Annual Cash Flow Conversion Efficiency for COMPASS PATHW SP.ADR (2021–2025)

The table below shows the annual cash flow conversion efficiency of COMPASS PATHW SP.ADR from 2021 to 2025. View COMPASS PATHW SP.ADR share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €-52.85 Million
≈ $-61.78 Million
€-157.24 Million
≈ $-183.83 Million
2.975x +486.18%
2024-12-31 €154.69 Million
≈ $180.85 Million
€-119.19 Million
≈ $-139.34 Million
-0.770x -78.61%
2023-12-31 €225.74 Million
≈ $263.92 Million
€-97.38 Million
≈ $-113.84 Million
-0.431x +25.85%
2022-12-31 €181.28 Million
≈ $211.94 Million
€-105.45 Million
≈ $-123.28 Million
-0.582x -144.21%
2021-12-31 €284.41 Million
≈ $332.51 Million
€-67.75 Million
≈ $-79.20 Million
-0.238x --

About COMPASS PATHW SP.ADR

F:5Y6 Germany Medical Care Facilities
Market Cap
$841.91 Million
€720.13 Million EUR
Market Cap Rank
#10886 Global
#1258 in Germany
Share Price
€7.50
Change (1 day)
-3.23%
52-Week Range
€2.12 - €8.15
All Time High
€48.20
About

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as … Read more